Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Garden Lee"'
Autor:
Chang Gon Kim, Moonki Hong, Hei-Cheul Jeung, Garden Lee, Hyun Cheol Chung, Sun Young Rha, Hyo Song Kim, Choong-kun Lee, Ji Hyun Lee, Yejeong Han, Jee Hung Kim, Seo Young Lee, Hyunki Kim, Su-Jin Shin, Song-Ee Baek, Minkyu Jung
Publikováno v:
European Journal of Cancer. 172:387-399
Investigations for programmed cell death-1 (PD-1) blockade-induced hyperprogressive disease (HPD) have not been stringently conducted in patients with advanced gastric cancer (AGC). We explored the occurrence of HPD and its clinical implications in p
Autor:
Han Sang Kim, DooA Kim, Eun Hwa Kim, Garden Lee, Yu Rang Park, Kyung A. Kim, Ho Yeon Cho, Si Won Lee, Beodeul Kang, Youn Jung Hu, Bori Lee, Hye Jin Choi
Publikováno v:
European Journal of Cancer Care. 29
OBJECTIVES Although early palliative care is associated with a better quality of life and improved outcomes in end-of-life cancer care, the criteria of palliative care referral are still elusive. METHODS We collected patient-reported symptoms using t
Autor:
Garden Lee, Han Sang Kim, Si Won Lee, Eun Hwa Kim, Bori Lee, Youn Jung Hu, Beodeul Kang, Hye Jin Choi
Background: Although early palliative care is associated with a better quality of life and improved outcomes in end-of-life cancer care, the criteria of palliative care referral are still elusive. Methods: We collected patient-reported symptoms using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6afa44f5d8fe967ff0e72a8df29cb177
https://doi.org/10.21203/rs.2.16484/v1
https://doi.org/10.21203/rs.2.16484/v1
Autor:
Hyo Song Kim, Garden Lee, Woo Sun Kwon, Sun Young Rha, Yeun-Jun Chung, Seung-Hyun Jung, Jun Hyeok Heo, Beodul Kang, Hyun Cheol Chung, Jii Bum Lee
Publikováno v:
Molecular Cancer Therapeutics. 18:B049-B049
Background: Recent advancements in immune checkpoint inhibitors (ICIs) have revolutionized treatment options in many solid cancers. Pembrolizumab and nivolumab, an anti-programmed death ligand 1 (anti PD-L1) agent, has approved in treatment of advanc
Autor:
Sun Young Rha, Woo Sun Kwon, Jihyun Hwang, Garden Lee, Hyun Cheol Chung, Sejung Park, Jii Bum Lee, Jinseul Park, Choong-kun Lee
Publikováno v:
Molecular Cancer Therapeutics. 18:C106-C106
Background: The prevalence of microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) and Lynch syndrome with germline MMR mutations in gastric cancer (GC), are 5% and 1.6%, respectively. According to TCGA data, BRCA mutations, one of